Βk-2C-I
Pharmaceutical compound
From Wikipedia, the free encyclopedia
βk-2C-I, or bk-2C-I, also known as β-keto-4-iodo-2,5-dimethoxyphenethylamine or as β-keto-2C-I, is a psychedelic drug of the phenethylamine and 2C families related to 2C-I.[1][2] It is the β-keto derivative of 2C-I and is cathinone-like in chemical structure.[1][2] The drug is closely related to βk-2C-B.[1][2] It is said to have a longer duration than 2C-I and to not be as intense in its effects as βk-2C-B.[1] Concerns have been expressed about the potential toxicity of the iodine in βk-2C-I.[1] The interactions of βk-2C-I with monoamine oxidase have been studied.[2] βk-2C-I was encountered as a novel designer drug online by at least 2016 and was first described in the scientific literature by 2018.[1] βk-2C-I is a controlled substance in Canada under phenethylamine blanket-ban language.[3]
- None
| |
| Clinical data | |
|---|---|
| Other names | bk-2C-I; β-Keto-2C-I; β-Keto-4-iodo-2,5-dimethoxyphenethylamine; 4-Iodo-2,5-dimethoxy-β-ketophenylethylamine; 4′-Iodo-2′,5′-dimethoxy-2-aminoacetophenone; 4-Iodo-2,5-dimethoxycathinone; 2,5MeO,4I-AcP |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H12INO3 |
| Molar mass | 321.114 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
